UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 97

Sortiert nach

Rifaximin for the Treatment of Hepatic Encephalopathy

Transplantation proceedings, 2010-12, Vol.42 (10), p.4543-4547

2010

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Tolerability of Rifaximin in Combination With Lactulose in End-stage Liver Disease Patients With MELD Greater Than 20: A Single Center Experience

Transplantation proceedings, 2014-12, Vol.46 (10), p.3481-3486

2014

Link zum Volltext

Verfügbarkeit prüfen

Prevention of allograft HCV recurrence with peri‐transplant human monoclonal antibody MBL‐HCV1 combined with a single oral direct‐acting antiviral: A proof‐of‐concept study

Journal of viral hepatitis, 2017-03, Vol.24 (3), p.197-206

2017

Link zum Volltext

Verfügbarkeit prüfen

Grazoprevir plus peginterferon and ribavirin in treatment-naive patients with hepatitis C virus genotype 1 infection: a randomized trial

Journal of viral hepatitis, 2016-02, Vol.23 (2), p.80-88

2016

Link zum Volltext

Verfügbarkeit prüfen

Hepatic proton density fat fraction correlates with histologic measures of steatosis and is responsive to change in those measures in a multi-center nonalcoholic steatohepatitis clinical trial

Journal of hepatology, 2017, Vol.66 (1), p.S668-S668

2017

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir with ribavirin in adults with genotype 1 or genotype 4 chronic hepatitis C virus infection and child-pugh B decompensated cirrhosis

Journal of hepatology, 2017, Vol.66 (1), p.S728-S729

2017

Link zum Volltext

Verfügbarkeit prüfen

Potentiostatic regeneration of oxygen reduction activity in MnOx @ graphene hybrid nanostructures

Electrochimica acta, 2019-12, Vol.325, p.134947, Article 134947

2019

Link zum Volltext

Verfügbarkeit prüfen

Oxygen reduction activity of Fe/Co/Ni doped MnOx @ graphene nanohybrid: A comparative study

Journal of electroanalytical chemistry (Lausanne, Switzerland), 2022-01, Vol.904, p.115767, Article 115767

2022

Link zum Volltext

Verfügbarkeit prüfen

Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio

Molecular genetics and metabolism, 2013-12, Vol.110 (4), p.446-453

2013

Link zum Volltext

Verfügbarkeit prüfen

O114 RESULTS OF THE PHASE 2 STUDY M12-999: INTERFERON-FREE REGIMEN OF ABT-450/R/ABT-267 + ABT-333 + RIBAVIRIN IN LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HCV GENOTYPE 1 INFECTION

Journal of hepatology, 2014-04, Vol.60 (1), p.S47-S47

2014

Link zum Volltext

Verfügbarkeit prüfen

P1134 DURATION OF UNDETECTABLE HCVRNA IN PATIENTS TREATED WITH FALDAPREVIR–DELEOBUVIR INTERFERON-FREE COMBINATION IS ASSOCIATED WITH SVR

Journal of hepatology, 2014-04, Vol.60 (1), p.S459-S460

2014

Link zum Volltext

Verfügbarkeit prüfen

O33 SVR AND SAFETY OF LOWER DOSES OF MK-5172 25 mg AND 50 mg DAILY FOR 12 WEEKS IN HCV GENOTYPE (G)1 TREATMENT-NAIVE NON-CIRRHOTIC PATIENTS

Journal of hepatology, 2014-04, Vol.60 (1), p.S14-S14

2014

Link zum Volltext

Verfügbarkeit prüfen

248 FASTING AMMONIA (NH3) AS A PREDICTOR OF HEPATIC ENCEPHALOPATHY (HE) EVENTS

Journal of hepatology, 2013-04, Vol.58, p.S106-S106

2013

Link zum Volltext

Verfügbarkeit prüfen

Investigation on structural, dielectric and conduction properties of BaTi0.95Sn0.05O3 ceramic

AIP Conference Proceedings, 2020, Vol.2244 (1)

2020

Link zum Volltext

Verfügbarkeit prüfen

Open-label study of faldaprevir plus peginterferon and ribavirin in hepatitis C virus genotype 1-infected patients who failed placebo plus peginterferon and ribavirin

Journal of viral hepatitis, 2016-03, Vol.23 (3), p.227-231

2016

Link zum Volltext

Verfügbarkeit prüfen

Functional molecule guided evolution of MnO x nanostructure patterns on N-graphene and their oxygen reduction activity

RSC advances, 2019-09, Vol.9 (48), p.27945-27952

2019

Link zum Volltext

Verfügbarkeit prüfen

Understanding the oxygen evolution activity trend in Co2Fe LDH‐N doped graphene hybrids

Electrochemical science advances, 2021-02, Vol.1 (1), p.n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

P1121 EARLY STOPPING RULES FOR FALDAPREVIR PLUS PEGYLATED INTERFERON a-2a AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS: EXPLORATORY STUDY OF POOLED DATA FROM PHASE III TRIALS

Journal of hepatology, 2014-04, Vol.60 (1), p.S452-S453

2014

Link zum Volltext

Verfügbarkeit prüfen

P1118 NO EFFECT OF FALDAPREVIR ON RENAL FUNCTION IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION: POOLED DATA FROM TWO PHASE III TRIALS

Journal of hepatology, 2014-04, Vol.60 (1), p.S451-S451

2014

Link zum Volltext

Verfügbarkeit prüfen

Stimulation of electrocatalytic oxygen reduction activity on nitrogen doped graphene through noncovalent molecular functionalisation

Chemical communications (Cambridge, England), 2016-01, Vol.52 (68), p.10385-10388

2016

Link zum Volltext

Verfügbarkeit prüfen

Functional molecule guided evolution of MnOx nanostructure patterns on N-graphene and their oxygen reduction activity

RSC advances, 2019, Vol.9 (48), p.27945-27952

2019

Link zum Volltext

Verfügbarkeit prüfen

ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV

The New England journal of medicine, 2014-05, Vol.370 (21), p.1983-1992

2014

Link zum Volltext

Verfügbarkeit prüfen

Liver transplantation in sickle cell anemia: a case of acute sickle cell intrahepatic cholestasis and a case of sclerosing cholangitis

Transplantation, 2005-12, Vol.80 (11), p.1630

2005

Link zum Volltext

Verfügbarkeit prüfen

Peginterferon Alfa-2a and Ribavirin in Latino and Non-Latino Whites with Hepatitis C

The New England journal of medicine, 2009-01, Vol.360 (3), p.257-267

2009

Link zum Volltext

Verfügbarkeit prüfen

Responsiveness of controlled attenuation parameter (CAP) and its correlation with magnetic resonance imaging-proton density fat fraction (MRI-PDFF) in a multi-center clinical trial of subjects with nonalcoholic steatohepatitis (NASH)

Journal of hepatology, 2018-04, Vol.68, p.S564

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 97

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(94)
Mit Volltextzugriff
(85)

Publikationsform

Sprache

Englisch
(96)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(42)
Life Sciences & Biomedicine
(21)
Humans
(20)
Physical Sciences
(19)
Physics
(17)
Female
(13)
Male
(13)
Adult
(11)
Ecce
(11)
Gastroenterology And Hepatology
(11)
Middle Aged
(11)
Technology
(11)
Ceramics
(10)
Gastroenterology & Hepatology
(10)
Instrumentation Related To Nuclear Science And Technology
(9)
Aged
(8)
Biological And Medical Sciences
(8)
Medical Sciences
(8)
Physics, Nuclear
(8)
Electron Ion Collider
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Rifaximin for the Treatment of Hepatic Encephalopathy

Efficacy and Tolerability of Rifaximin in Combination With Lactulose in End-stage Liver Disease Patients With MELD Greater Than 20: A Single Center Experience

Prevention of allograft HCV recurrence with peri‐transplant human monoclonal antibody MBL‐HCV1 combined with a single oral direct‐acting antiviral: A proof‐of‐concept study

Grazoprevir plus peginterferon and ribavirin in treatment-naive patients with hepatitis C virus genotype 1 infection: a randomized trial

Hepatic proton density fat fraction correlates with histologic measures of steatosis and is responsive to change in those measures in a multi-center nonalcoholic steatohepatitis clinical trial

Efficacy and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir with ribavirin in adults with genotype 1 or genotype 4 chronic hepatitis C virus infection and child-pugh B decompensated cirrhosis

Potentiostatic regeneration of oxygen reduction activity in MnOx @ graphene hybrid nanostructures

Oxygen reduction activity of Fe/Co/Ni doped MnOx @ graphene nanohybrid: A comparative study

Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio

O114 RESULTS OF THE PHASE 2 STUDY M12-999: INTERFERON-FREE REGIMEN OF ABT-450/R/ABT-267 + ABT-333 + RIBAVIRIN IN LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HCV GENOTYPE 1 INFECTION

P1134 DURATION OF UNDETECTABLE HCVRNA IN PATIENTS TREATED WITH FALDAPREVIR–DELEOBUVIR INTERFERON-FREE COMBINATION IS ASSOCIATED WITH SVR

O33 SVR AND SAFETY OF LOWER DOSES OF MK-5172 25 mg AND 50 mg DAILY FOR 12 WEEKS IN HCV GENOTYPE (G)1 TREATMENT-NAIVE NON-CIRRHOTIC PATIENTS

248 FASTING AMMONIA (NH3) AS A PREDICTOR OF HEPATIC ENCEPHALOPATHY (HE) EVENTS

Investigation on structural, dielectric and conduction properties of BaTi0.95Sn0.05O3 ceramic

Open-label study of faldaprevir plus peginterferon and ribavirin in hepatitis C virus genotype 1-infected patients who failed placebo plus peginterferon and ribavirin

Functional molecule guided evolution of MnO x nanostructure patterns on N-graphene and their oxygen reduction activity

Understanding the oxygen evolution activity trend in Co2Fe LDH‐N doped graphene hybrids

P1121 EARLY STOPPING RULES FOR FALDAPREVIR PLUS PEGYLATED INTERFERON a-2a AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS: EXPLORATORY STUDY OF POOLED DATA FROM PHASE III TRIALS

P1118 NO EFFECT OF FALDAPREVIR ON RENAL FUNCTION IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION: POOLED DATA FROM TWO PHASE III TRIALS

Stimulation of electrocatalytic oxygen reduction activity on nitrogen doped graphene through noncovalent molecular functionalisation

Functional molecule guided evolution of MnOx nanostructure patterns on N-graphene and their oxygen reduction activity

ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV

Liver transplantation in sickle cell anemia: a case of acute sickle cell intrahepatic cholestasis and a case of sclerosing cholangitis

Peginterferon Alfa-2a and Ribavirin in Latino and Non-Latino Whites with Hepatitis C

Responsiveness of controlled attenuation parameter (CAP) and its correlation with magnetic resonance imaging-proton density fat fraction (MRI-PDFF) in a multi-center clinical trial of subjects with nonalcoholic steatohepatitis (NASH)

Suchergebnisse filtern